Brighton Jones’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding HRTX
Brighton Jones's HRTX Position: Q3 2026 in Review
Brighton Jones sold out of Heron Therapeutics (HRTX) in Q3 2026, closing a stake of 11,133 shares — an estimated $4.75K sold.
Brighton Jones first reported a position in HRTX in Q2 2026 and held it in 1 quarter. The position peaked at $4.75K in Q2 2026. 131 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.
- Brighton Jones reported no remaining Heron Therapeutics position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 11,133 Heron Therapeutics shares in Q3 2026, an estimated $4.75K.
- Brighton Jones first reported a position in Heron Therapeutics in Q2 2026 and held it in 1 quarter.
- Brighton Jones's Heron Therapeutics position peaked at $4.75K in Q2 2026.
- 131 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.